Skip to content
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board Committee
      • Board of Directors
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
      • Yuan Zhi, PhD – B Riley Securities
      • Lake Street Capital Markets – Ben Hayor
  • Contact
Nutex Health
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board Committee
      • Board of Directors
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
      • Yuan Zhi, PhD – B Riley Securities
      • Lake Street Capital Markets – Ben Hayor
  • Contact
by Nutex
August 14, 2025

NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION

HOUSTON, Aug. 14, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), […]
0
read more
  • X (twitter)
  • facebook
  • linked in

1776 Yorktown St Suite 700

Houston, TX 77056

713-660-0557

info@nutexhealth.com

  • Home
  • Investors
  • Contact
  • Whistleblower
  • Home
  • Investors
  • Contact
  • Whistleblower

© 2026

Sign Up for Investor News & More

email alerts
© 2026 Nutex Health